Stand no: 16B25
Mallinckrodt and its former parent company, Tyco/Healthcare, are now Covidien, a $10 billion global leader in pharmaceuticals, medical devices/supplies, diagnostic imaging agents, and other products and services. As part of Covidien, we are better positioned than ever to manufacture your solid dose and oral liquid pharmaceutical products on time and within budget. We draw on the knowledge and experience of more than 42,000 professionals who are committed to providing you with flexible and responsive service. Our focus is on creating long-term partnerships that give your products the level of accountability and attention they deserve.